Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition

A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence New System Rounds Out CT Portfolio that Provides Clinicians with Innovative Cardiac Capabilities

Canon Medical notes to meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete CT solution with proven cardiovascular capabilities. The Aquilion ONE / GENESIS SP was designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its AI-powered wide-area CT.

Canon Medical reports the Aquilion ONE / GENESIS SP enhances Canon Medical’s suite of Collaborative imaging tools which deliver clarity and confidence across the patient care cycle. Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process — from evaluation to treatment, offering a wide range of features for complete cardiac care, including innovative CT technologies such as:

  • Improved diagnostic confidence across patients with one-beat, whole-heart acquisition and Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), which enables clinicians to obtain sharp, clear and distinct images.
  • Enhanced workflow capabilities because of automated tools from acquisition through analysis such as SURECardio and Vitrea Advanced Visualization, which can help clinicians manage their new increase in patient volume, and also deliver proven consistency in high image quality.
  • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and Power Save Mode improvements that enable the Aquilion ONE GENESIS / SP to require less cost to operate.
  • Patient-centric enhancements to help improve safety, comfort and access, including a wide bore (78 cm) and wide (47 cm) and low (33 cm) couch.

“Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. At Canon Medical, we are committed to providing technologies that help clinicians keep pace with these evolving clinical pathways,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Canon Medical’s CT product line, including the Aquilion ONE / GENESIS SP, is designed to offer complete cardiac capabilities. The platform was designed to be intuitive, making the acquisition of high-quality images easy and reliable across the full spectrum of patients and clinical scenarios.”

Canon Medical is showcasing the all-new Aquilion ONE / GENESIS SP and its full suite of innovative cardiac capabilities for high-quality routine cardiac imaging at this year’s virtual Society of Cardiac Computed Tomography (SCCT) annual meeting. Visit the booth here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”